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ABSTRACT
The study of the evolution and phylogeny of West Nile virus (WNV) has been an
important area of research since the introduction of WNV in 1999. However, genome
sequencing of isolates from the Southeastern part of the United States has been somewhat
limited. To determine how WNV has evolved at a more localized level, ten isolates from
Florida and Georgia from 2003-2012 were completely sequenced using Illumina’s nextgeneration technology. In addition, a phylogenetic comparison of both the complete
genome and select partial genomes was completed to ensure consistency among the
results. This study further demonstrated the dominance of the North American WN02
genotype within the Southeastern United States. In addition, phylogenetic analyses
revealed the continued presence of genetic variance in 2012 with the finding of a new
group within the North American clade. In conclusion, WNV has continued to evolve
within the Southeastern US.
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CHAPTER ONE: INTRODUCTION
West Nile virus (WNV, Flaviviridae: Flavivirus) entered the United States in the
summer of 1999, when infected humans were diagnosed in New York State (Lanciotti et
al., 1999; Strausbaugh et al., 2001) . To the surprise of the scientific community, the virus
reached the West Coast in only four years (personal communication, T. Unnasch; CDC,
2013b) with major regional epidemics in 2002 and 2003(CDC, 2013b), bringing with it
major economic and public health impact. Since its emergence in 1999 through 2010 an
estimated two million people were infected with an estimated 360,000 illnesses
(Kilpatrick, 2011). From 1999 to 2012 more than 37,000 cases (CDC, 2013a) were
reported to the CDC, over 16,000 encephalitis/meningitis, and approximately 1,500
deaths (CDC, 2013b, c). In 2012, a multistate outbreak of WNV disease accounted for
5,674 (98%) of reported cases (CDC, 2013c); the highest number reported since 2003
(CDC, 2013b, c). Of the total 5,674 WNV disease cases, 51% were neuroinvasive at
2,873 case reports (CDC, 2013c). This year, as of 10 September 2013, the US Geological
Survey (USGS) reported a total of 696 cases (USGS, 2013) which appear to be clustered
around the Midwest (South Dakota-Minnesota- Colorado) and California. With the
prevalence and burden of disease increasing, the question is then, is West Nile virus
continuing to evolve and if so, is this genetic variation the cause of its reemergence?
The thought, after WNV entered the US in 1999, was that the virus would travel
with the migration of the birds (North to South), and it did initially (May et al., 2011;
Peterson et al., 2003; Rappole et al., 2006; Zehender et al., 2011), appearing in Florida as
1

predicted in 2001(CDC, 2013b). Then surprisingly, in 2002, the virus presented
differently from what was expected, moving West with Illinois being its biggest target,
thus weakening the initial hypothesis (CDC, 2013b). Strikingly, the virus reached
California, peaking in 2004 with 779 case reports; a dramatic shift from the previous
year’s reported three cases (CDC, 2013b). Continued increase of incidence of the virus
across the Western region lead to extensive research involving WNV, its globalization,
molecular epidemiological, and ecologically contributing factors. WNV is maintained in
nature in an enzootic cycle involving birds and mosquitos (Bernard et al., 2001; Pesko
and Ebel, 2012) and can be considered an “ecological generalist” (Pesko and Ebel, 2012)
due to its ability to be transmitted between a large variety of hosts (Bernard et al., 2001;
Pesko and Ebel, 2012).
Previous molecular epidemiological studies of WNV have shown genetically
distinct variants that group in a temporally and geographically dependent manner
(Anderson et al., 2001; Armstrong et al., 2011; Beasley et al., 2003; Bertolotti et al.,
2007; Davis et al., 2005; Ebel et al., 2004; Ebel et al., 2001; McMullen et al., 2011;
Pesko and Ebel, 2012). Several studies have provided evidence of the displacement and
perhaps extinction of the earlier progenitor genotypes to include NY99 with a dominant
genetic variant notably named North America WN02 genotype; differing only by 1 amino
acid and 13 silent nucleotide changes (Anderson et al., 2001; Armstrong et al., 2011;
Beasley et al., 2003; Bertolotti et al., 2007; Davis et al., 2005; Ebel et al., 2004; Ebel et
al., 2001; McMullen et al., 2011). Several genetic variants of WNV have arisen in certain
geographical areas such as Texas genotype SW/WN03 and the Idaho/North Dakota
genotype MW/WN06. The potentially newly emerging SW/WN03 genotype contains
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several amino acid changes relative to the WN02 genotype and is reportedly spreading
through numerous states. However, the phenotypic associations for the SW/WN03
genotype and the MW/WN06 have not been well characterized (Añez et al., 2013;
McMullen et al., 2011; Pesko and Ebel, 2012). Genetic diversity along with geographical
expansion appears to continue throughout the years. To further characterize the
evolutionary patterns of WNV within the Southeastern US, and represent the current state
of WNV evolution at a localized level, 10 samples were chosen during the course of ten
years.
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CHAPTER TWO: OBJECTIVES
After West Nile Virus had been introduced in the summer of 1999 and the
prediction of the virus spreading in a pattern that followed the migrating birds, Florida
was considered a potentially important area (personal communication, T. Unnasch). In
addition to the patterns of the migrating birds, Florida’s geographic, climatological, and
demographic conditions provided ideal environment for the Culex mosquito, the primary
transmission vector of WNV, thus giving aid to transmission rates (Chisenhall and
Mores, 2009). Surprisingly, the predicted high levels of transmission or disease outbreaks
have not been observed, with its biggest year being 2003, much like the rest of the
country (CDC, 2013b). Unlike the rest of the country however, Florida’s case reports are
still relatively low (CDC, 2013b; USGS, 2013). This lack of intense WNV transmission
in Florida is not likely due to vector incompetence, but rather possible anthropogenic
reasons such as mosquito control programs (Chisenhall and Mores, 2009). A study in
2009 by Chisenhall and Mores sought to evaluate the role of viral strain diversity in
WNV transmission in Florida using isolates from mosquito pools collected in 2005.
Phylogenetic and amino acid analyses showed that all isolates appeared to have settled
within the North American (WN02) clade and the introduction into Florida occurred
sometime between 2003 and 2005 (Chisenhall and Mores, 2009). Since then, there have
been few studies on isolates from Florida, possibly due to decreasing incidence of disease
and low overall case reports. This study sought to further evaluate these past findings and
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thus the role of viral strain diversity in West Nile Virus transmission in Florida. This was
accomplished by carrying out a phylogenetic analysis of several isolates collected from
varied locations in Florida and two isolates from Georgia.
Until recently most phylogenetic analyses have been done on regions of the
genome such as the envelope (ENV) region. However, few whole genome analyses have
been conducted to date. The technical aspects involved in obtaining whole genome and
accessibility to more advanced technologies are more expensive and difficult. To my
knowledge, since this study, there has only been one whole genome sequencing analysis
(FL2001 crow 67030, GenBank accession no. GQ379156.1) completed for isolates in the
subtropical region of Florida with very few in Georgia. Therefore, whole genome
sequence analysis would be of value.
This study has three specific aims:
1. To establish a phylogeny method suitable for the evolutionary analyses of the
Florida/Georgia dataset.
2. To characterize phylogenetic relationship and nucleotide sequence homology for
Florida/Georgia isolates to previously reported isolates.
3. To study the evolution of West Nile Virus at a localized level.
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CHAPTER THREE: LITERATURE REVIEW
Molecular Biology and Replication
Structure and Genome
West Nile Virus (WNV) is a small enveloped, spherical virus with a positive
sense, single stranded RNA (Mukhopadhyay et al., 2003). The virion consists of an
envelope surrounding an icosahedral capsid approximately 50nm in size (Rossi et al.,
2010) which contains the genomic RNA(figure 1). Mature virions display a smooth outer
surface with no spikes or projections (Mukhopadhyay et al., 2003).

M
M
Nucleocapsid

Virion
envelope
Figure 1: Flavivirus Virion
The virion RNA is enclosed in an icosahedral nucleocapsid. The envelope is derived from
the host cell membranes. E glycoprotein is arranged as ‘head to tail’ homodimers and in
immature virions associates with the other integral membrane proteins prM protein
Used with permission, Peterson & Roehrig, 2001
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The genomic RNA consists of a single open reading frame coding for ten viral
proteins (most of which are involved in viral replication) that is approximately 11 kb with
no poly(A) tail at the 3’ end and is shown in figure 2 (Brinton, 2002; Lanciotti et al.,
1999). Replication, transcription, translation, and packaging are due to the unique stemloop structures formed by the 5’ and 3’ noncoding regions of the genome (about 96 and
635 nucleotides in length, respectively) (Fredericksen et al., 2004; Khromykh et al.,
2001; Shi et al., 1996).

Figure 2: West Nile virus genome organization.
The single open reading frame which encodes for both structural and nonstructural
proteins, flanked by two non-coding regions (NCRs).

Used with permission (Petersen & Roehrig, 2001)
The viral RNA is translated as a single polyprotein giving yield to three structural
(capsid (C), envelope (E), and premembrane (prM)) and seven nonstructural (NS1,
NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins (Brinton, 2002; Rice, 1996). The
majority of the nonstructural proteins in West Nile Virus are multifunctional, responsible
for regulating viral mechanisms of transcription, translation, and replication (Brinton,
2002; Campbell et al., 2002; Colpitts et al., 2012; Rice, 1996; Valiakos et al., 2013).

7

Replication Cycle
West Nile Virus is able to replicate in a wide range of species (mammal,
amphibian, avian, and insect) and cell cultures (Kilpatrick, 2011; Kilpatrick et al., 2005;
Mukhopadhyay et al., 2003; Reisen et al., 2005). The first step is cell entry which
involves the binding of E protein to a cellular molecule-receptor and several known coreceptors (Davis et al., 2006; Mukhopadhyay et al., 2003; Rey et al., 1995). After the
viral attachment via the cellular receptors, WNV is believed to enter the cell through
clathrin-mediated endocytosis (Rice, 1996; Smit et al., 2011). Clathrin-mediated
endocytosis is a form of receptor mediated endocytosis and is dependent on a hairpin-like
fold present in E glycoprotein (Smit et al., 2011; Valiakos et al., 2013). The acidic
endosome environment allows the E protein rafts to be disrupted (Smit et al., 2011;
Valiakos et al., 2013). The viral RNA is then released by the nucleocapsid by some
unknown mechanism and is translated (Khromykh et al., 2001; Rice, 1996; Valiakos et
al., 2013). Within the lumen of the endoplasmic reticulum, the newly produced
polyprotein is cleaved at multiple sites by the NS3 serine protease and the host signal
peptidase (Khromykh et al., 2001; Rice, 1996; Valiakos et al., 2013). Simultaneously, the
viral RNA-dependent RNA polymerase copies complementary negative polarity (–)
strands from the positive polarity genomic (+) RNA template that serve as templates for
the synthesis of new positive viral RNAs. West Nile virion assembly, morphogenesis,
and transport to the extracellular environment completes the replication cycle (Chu and
Westaway, 1987; Khromykh et al., 2001; Rice, 1996).

8

Classification and Epidemiology
The Flaviviridae family (from the Latin word flavus or “yellow” referring to the
prototype Yellow Fever virus) (Colpitts et al., 2012; Valiakos et al., 2013) has four
genera, including the Flavivirus, Pestivirus, Pegivirus and Hepacivirus (ICTV, 2012).
The genus Flavivirus includes about 53 viruses (ICTV, 2012) which can be further
classified as non-vector and vector borne (tick-borne and mosquito-borne) virus groups
(Colpitts et al., 2012; King et al., 2011; Kuno et al., 1998; Valiakos et al., 2013). The
mosquito-borne group is roughly sorted into the encephalitic clade, or the Japanese
Encephalitis virus serocomplex (Calisher et al., 1989), which includes West Nile virus
(WNV) and Japanese Encephalitis virus, and the nonencephalitic or hemorrhagic fever
clade, which includes Dengue Virus and Yellow Fever virus. Flaviviruses can be further
categorized into antigenic complexes and subcomplexes based on serological criteria or
into clusters, clades and species based on molecular phylogenetics (Calisher et al., 1989;
Lindenbach and Rice, 2003; Rice, 1996).

Molecular Classification
First classifications of WNV were based on cross-neutralization reactions
revealing that WNV is a member of the Japanese encephalitis virus serocomplex
(Calisher et al., 1989). Within the Japanese encephalitis virus serocomplex are other
neurovirulent viruses such as St. Louis encephalitis virus, Murray Valley encephalitis
virus, and Usutu virus (Beasley, 2005; Poidinger et al., 1996). Because of antigenic cross
reactivity between different ﬂaviviruses, techniques such as in situ hybridization or
sequence analysis of RT-PCR products are required in order to unmistakably identify
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WNV as the causative agent of an outbreak (Brinton, 2002; Kaufmann et al., 2009).
However, recent advances on molecular phylogeny provide support for this antigenic
classification, further revealing the existence of up to five distinct genetic lineages of
WNV (Lanciotti et al., 2002).
Based on signature amino acid substitutions and/or deletions in the envelope
protein, WNV isolates have been grouped into two major lineages (I and II)(Bakonyi et
al., 2005; Lanciotti et al., 1999), with the recent proposal of several additional lineages
that differ from one another by 5-25% (Vazquez, 2012; Bondre,2007).
Lineage I is probably the most studied and is well distributed throughout much of
the world. It can be further divided into several clades (Ebel and Kramer, 2009; Hall et
al., 2001; Lanciotti et al., 1999). Clade 1a includes African, European and American
isolates (NY99 and WN02); clade 1b groups the Australian Kunjin virus (KUNV), which
has been shown to be a subtype of WNV (Hall et al., 2001); and clade 1c groups isolates
from India (Beasley, 2005). The Martin-Acebes et al. (2012) study showed that clade 1a
displays close genetic relationships between geographically distant areas, shown to be
attributed to WNV introductions via migratory birds (Martín-Acebes and Saiz, 2012).
Lineage II was originally thought to have been restricted to sub-Saharan Africa
until 2004 when it was found to be associated with outbreaks of West Nile virus in
Eastern and Western Europe and established endemic cycles in Greece and Spain
(Bakonyi et al., 2006; Papa et al., 2010; Vázquez et al., 2010). It is typically associated
with less frequent neuroinvasion thus, less severe disease, but recent reports in South
Africa have described human and equine cases of encephalitis associated with lineage II
(Venter and Swanepoel, 2010)
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Other lineages of WNV of unknown human pathogenicity are lineage III.
“Rabensburg Virus”, was first isolated from Culex pipiens mosquitoes in the Czech
Republic in 1997 and 1999, and from a pool of Aedes rosicus in 2006 (Bakonyi et al.,
2005; Hubálek et al., 2010) . Lineage IV was found isolated in Russia from Dermacentor
marginatus ticks in 1998 and from mosquitoes in 2002 and 2005 (May et al., 2011).
Lineage V has been proposed to be comprised of WNV Indian isolates that were grouped
in lineage Ic (Bondre et al., 2007) and 13 isolates from India, collected from the 1950s
through 1980 (May et al., 2011). Lineages III and IV have not been associated with high
virulence and lineage III, only found in mosquitoes has yet to produce mortality in adult
infected mice (Bondre et al., 2007; Davis et al., 2005; Hubálek et al., 2010).

Molecular Epidemiology
NY99, the first North American WNV isolate was originally thought to be most
closely related to a strain isolated from a dead goose in Israel (lineage I) during the 1998
outbreak (Lanciotti et al., 1999), suggesting that the North American WNV was derived
from this Israel 1998 outbreak. However, recent data collected by May et al. (2011)
suggests that the epidemic in Israel in 1998 was not the direct progenitor of North
American epidemics, but rather that it is more closely related to isolates from both Israel
in 1998 and Hungary in 2003 (Jia et al., 1999; Lanciotti et al., 1999; May et al., 2011;
Zehender et al., 2011). Shortly after WNV was introduced into North America, the
process of evolution led to increases in the basic reproductive rate and additional
subtypes. One additional subtype of WNV, North American WN02, first detected in
samples isolated in Texas, presented with an amino acid substitution (E-V159A) in the
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envelope protein (Beasley et al., 2003). WN02 rapidly displaced NY99, becoming the
dominant genotype in North America in 2001 to 2003 (Beasley, 2005; Ebel et al., 2004).
Ebel et al. (2004) showed that the mechanism for the increased ﬁtness of WN02 relative
to NY99 was due to WN02 strains shortened extrinsic incubation period in mosquitoes
(Ebel et al., 2004).
Geographically, there was been a general lack of division among the sequences,
especially those that relied primarily on envelope region (Armstrong et al., 2011;
Bertolotti et al., 2007; Davis et al., 2007; Pesko and Ebel, 2012). Gray et al. (2010)
indicated that sequences from the envelope coding region may not be the most
phylogenetically informative after all, rather NS3 or NS5 coding regions might be more
suitable for partial sequence analysis and most closely resemble whole genome
phylogenetic studies (Gray et al., 2010). Recent whole genome studies however, were
able to uncover more evidence for geographical structure (Armstrong et al., 2011;
McMullen et al., 2011; Pybus et al., 2012).
Several distinct genetic variants of WNV have arisen in certain geographical areas
such as Texas genotype SW/WN03 and the Idaho/North Dakota cluster MW/WN06
(Añez et al., 2013; Davis et al., 2004; McMullen et al., 2011). The SW/WN03 genotype
contains several amino acid changes relative to the WN02 genotype and is reportedly
spreading through numerous states. However the phenotypic associations for the
SW/WN03 genotype and the MW/WN06 cluster have not been well characterized as
studies are still ongoing (Añez et al., 2013; McMullen et al., 2011; Pesko and Ebel,
2012).
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Whole genome phylogenetic analysis of global WNV isolates have discovered
influences on distribution of clade 1a (May et al., 2011; Zehender et al., 2011). Clade 1a
seem to have migrated to both Eastern and Western European countries and single
introductions in India and Australia in the 1970s and 1980s from a common ancestor that
excited in sub-Saharan Africa in the early 20th century (May et al., 2011; Zehender et al.,
2011). As discussed previously the patterns of distribution from Africa to Europe seem to
have followed the route of migratory birds, specifically the white stork, thus indicating
that bird species played and play an important role in the spread of WNV (May et al.,
2011; Pesko and Ebel, 2012; Zehender et al., 2011).

Genomic Diversity
Molecular epidemiologic studies such as those discussed previously have
provided understanding into the selective forces that act on WNV. It is clear that the virus
is rapidly evolving and bears the capacity to adapt to a wide range of hosts and
environments (Pesko and Ebel, 2012). These ﬁndings have inspired further research
aimed at better understanding the viral population genetic mechanisms. Early studies
within hosts evaluated whether the two very different kinds of host required for WNV
vitality (mosquitoes and birds) inﬂuence the WNV population in different ways (Bernard
et al., 2001; Jerzak et al., 2005; Jerzak et al., 2007; Jerzak et al., 2008; Kilpatrick, 2011;
Reisen et al., 2005). These studies suggested that within hosts, WNV forms a genetically
intricate distribution of mutants that vary in their degree of nucleotide divergence from
the population consensus sequence. Furthermore, Jerzak et al. (2005) showed that WNV
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populations in infected birds are relatively genetically similar but very diverse when
collected from infected mosquitoes (Jerzak et al., 2005).
Nevertheless, the Jerzal et al (2007) study and several other studies have clearly
established that mosquitoes and birds exert different evolutionary pressures on WNV.
Similar to that of other RNA viruses, WNV exhibits significant genetic diversity, which
is mostly due to the high mutation rates that occur during RNA replication and the
subsequent selection of mutants adapted to changing environment (Koo et al., 2009).
Since mutations that are detrimental to viral fitness are constrained, variability is uneven
across the viral genome. Therefore, while certain protein sites permit multiple mutations,
sites essential to viral structure-function are evolutionarily strong and highly conserved
(Condit, 2007; Flint et al., 2009; Koo et al., 2009). Specifically, the NS5 protein is known
to be one the most conserved across Flavivirus proteins. In a 2009 study, entropy analysis
revealed numerous highly conserved and evolutionarily stable WNV sequences
distributed throughout the viral proteins (Koo et al., 2009). These results were indicative
of high genetic stability of WNV, despite its adaptability and continuous global
emergence (Koo et al., 2009).

Public Health Implications
Transmission
West Nile Virus is primarily transmitted by Culex mosquitos (Bernard et al.,
2001). Birds are considered to be the amplifying hosts while humans, horses, and most
other mammals are incidental or “dead-end” hosts because they do not produce
significant viremia (viral loads) and do not contribute to the transmission cycle (Bernard
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et al., 2001; Reisen et al., 2005). The infectious female mosquito carries virus particles in
her salivary glands and infects the bird during her blood meal. Interestingly, West Nile
virus has been isolated in about 60 mosquito and 300 bird species, but is only found to be
predominate in less than ten mosquitos and a select few birds (Bernard et al., 2001;
Reisen et al., 2005). The bird, upon viral exposure, will sustain an infectious viremia for
about 1-4 days and survivors maintain life-long immunity (Dauphin and Zientara, 2007;
Komar et al., 2003; McLean et al., 2001). As discussed previously, birds, notably
migrating birds, also have been associated with the spreading of WNV throughout its
distribution (May et al., 2011; Peterson et al., 2003; Rappole et al., 2006; Zehender et al.,
2011). A wide variety of birds have been found infected by WNV, but the species most
important to virus continuation has the tendency to vary by location (Bernard et al., 2001;
Kilpatrick, 2011; Kilpatrick et al., 2006).
Serological studies have shown that WNV is able to infect a very large number of
vertebrate species including mammals, amphibians and reptile making WNV an
“ecological generalist” (Bernard et al., 2001; Dauphin and Zientara, 2007; Komar et al.,
2003; May et al., 2011; McLean et al., 2001; Pesko and Ebel, 2012; Peterson et al., 2003;
Rappole et al., 2006; Zehender et al., 2011). Other naturally occurring transmissions
include blood transfusions (thereby leading to the advent of blood product screening),
breast feeding, trans-placentally, organ transplantation, and accidental laboratory
acquired transmission (Dauphin and Zientara, 2007).

15

WNV Disease: Human Manifestations
Although humans are susceptible to infection, most cases are asymptomatic
(Petersen and Marfin, 2002; Sejvar et al., 2003). Approximately 20% of the human cases
result in mild febrile illness with less than 1% developing more severe neurological
disease (Petersen and Marfin, 2002; Sejvar et al., 2003). The development of neurological
disease can last several weeks and in some cases cause permanent sequelae (Campbell et
al., 2002; Petersen and Marfin, 2002; Sejvar et al., 2003). Severe progression of
neurological disease may induce flaccid paralysis (polio-like syndrome) that may
progress to all four limbs and has a poor long term outcome (Saad et al., 2005)
Elderly populations (over 70 years of age) are most susceptible to the severe
forms of infection that ultimately lead to death (Campbell et al., 2002; Petersen and
Marfin, 2002; Sejvar et al., 2003). Among the elderly populations that develop severe
neurological illness, about 50% will have significant post-illness morbidity for up to one
year and increased risk of dying for up to 3 years post infection with a case fatality rate
range of 15% to 29% (Campbell et al., 2002; Petersen and Marfin, 2002; Sejvar et al.,
2003). In addition, infants and immunocompromised populations are also at increased
risk for developing severe forms of infection (Petersen and Marfin, 2002).

16

CHAPTER FOUR: MATERIALS AND METHODS
Collection and Study Samples
The ten isolates used in this study were collected from Florida and Georgia, and
are listed, along with their metadata, in Table 1. Samples collected from Florida were
collected from six counties from Northern Florida and the Panhandle (Figure 4). The two
Georgia samples were collected in Mitchell County (figure 4). All samples were collected
from August 2003 to October 2012 and were randomly picked by year.

Virus Isolation and RNA Extraction
All samples were sent to Florida Department of Health- Bureau of Public Health
Laboratories (FDOH-Tampa) in Tampa for necropsy and further processing to confirm
West Nile Virus. Tissues were prepared in Biological Field Diluent (BFD) with either
copper or glass BBs and supernatant was removed and placed in instrument specific lysis
buffer. Tissues were homogenized again in the MM300 Mixer Mill (Qiagen), centrifuged,
and supernatant removed and transferred for RNA extraction or placed into culture, or
both. RNA extractions methods varied over the nine year period in which these samples
were isolated and included, but were not limited to, manual extraction using spin column
(ie.Qiagen QIAamp Kits) or automated methods such as Roche MagNA Pure LC and
QIAcube. Samples were confirmed WNV positive by real time RT-PCR.
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Table 1: West Nile Virus Isolates Sequenced for this Study
Sequences/Abbreviations

Isolate

Collection date

County

State

Species

Tissue

Passage
history

GA 2012-028

I12-028

8/14/2012

Mitchell

GA

Lorikeet

pool

V1

GA 2012-030

I12-030

8/31/2012

Mitchell

GA

Lorikeet

pool

V1

FL 2012-041

I12-041

10/18/2012

Alachua

FL

Crow

brain

V1

FL 2009-085

I09-85

10/26/2009

Alachua

FL

Crow

heart

V1

FL 2009-086

I09-86

10/26/2009

Alachua

FL

Crow

heart

V

FL 2004-455

I04-455

8/20/2004

Dade

FL

Blue jay

heart

V1

FL 2003-1354

I03-1354

8/12/2003

Levy

FL

Hawk

heart

V1

FL 2003-1396

I03-1396

7/17/2003

Wakulla

FL

Blue jay

heart

V1

FL 2003-1406

I03-1406

8/12/2003

Union

FL

Blue jay

heart

V1

FL 2003-1952

I03-1952

9/23/2003

Washington

FL

Titmouse

heart

V1

Note: V1 = RNA extracted from first passage in Vero cells
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Figure 3: Locations of collected isolates, 2003-2012
Map of Florida (right) and Georgia (lower left) showing the geographic location of WNV
isolates sequenced and analyzed in this study. Each isolate is indicated by an asterisk (*).

Used with Permission, World Atlas 2013
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Samples were inoculated onto Vero cell monolayer (at 80-90% confluence) in
25cm2 flasks using a sterile 1ml pipet, rocked at 37°C for 1 to 2 hours and fed with 10ml
feed media. Cultures were incubated once more and checked for cytopathic effect (CPE)
at 37°C for fourteen days.
Cultures were sent frozen, in one milliliter vials, to Texas Biomedical Research
Institute. Samples were inactivated and homogenized using 3:1 ratio of TRIzol® LS
reagent (Ambion│RNA by Life Technologies, Cat. no. 10296-010/ 10296-028) to
sample. Homogenized samples were taken through phase separation according to
TRIzol® LS reagent manufacturer’s protocol (Ambion®│RNA, 2010). The aqueous
phase was then transferred into a new tube and processed further for RNA isolation,
according to manufacturer’s protocol. Because the quantity of RNA in the samples were
unknown at this point, RNase-free glycogen, GlycoBlue™ (lot no. 1212026)
(Ambion®│RNA, 2010) was added, as suggested by manufacturer, to serve as coprecipitant with RNA. At low concentrations, less than or equal to 4mg/mL, glycogen
would assist in precipitating RNA from small samples as a carrier to the aqueous phase
without inhibiting first-strand synthesis and PCR (Ambion®│RNA, 2010). Isolates were
washed, resuspended in 20µL of RNase-free water, and stored at −80°C. All samples
were isolated as described above.

Sample Cleanup and Preparation
Samples used in this study, with the exception of the three 2012 samples, were all
archive samples that had been stored for up to nine years. To test quality and content of
the frozen samples, two samples, WN12-028 and WN03-1406, were initially chosen
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randomly and processed according to TruSeq RNA Sample Preparation guide
(Illumina®, 2012).
Upon completion of sample preparation and sequencing, a BLAST search of
several contigs showed slight 16S ribosomal RNA contamination, therefore the
remaining samples were processed with an additional RNA cleanup workflow to allow
for “cleaner” downstream analysis.

RNA Cleanup
RNA cleanup was performed to remove any DNA contaminates from the RNA
samples by first, removing any remaining DNA contaminants using TURBO DNAfree™ Kit (Ambion®, 2012). The kit contains TURBO™ DNase, DNase Buffer, DNase
inactivation reagent, and nuclease-free water (Cat. no. AM1907). Isolates were processed
according to manufacturer suggested protocol and based on elution volumes (Ambion®,
2012).
Isolates were cleaned further using Ribo-Zero™Magnetic Gold Kit (Cat. no.
MRZE724) by Epicentre® (Epicentre®, 2012; Lim et al., 2012) for rRNA removal
utilizing magnetic beads. Magnetic beads were washed and primed with RiboGuard™
Rnase Inhibitor. RNA samples were treated with Ribo-Zero rRNA removal solution
based total RNA sample volume. The treated RNA samples were then added to the
washed magnetic beads, mixed, incubated and centrifuged according to manufacturer’s
protocol (Epicentre®, 2012; Lim et al., 2012).
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Isolates now DNA and rRNA free, were taken into a removal of polyadenylated
RNA (mRNA) procedure using TruSeq RNA Sample Prep Kit (Illumina®, 2012). RNA
purification beads and short incubations were used to bind and remove poly A RNA.
Following the removal of polyadenylated RNA, samples were purified and
concentrated using RNA Clean & Concentrator™-5 by Zymo Research The procedure is
based on a RNA Binding Buffer and ethanol, to adjust for the binding conditions, that is
added to the samples, put through a series of washes, and eluted the concentrated RNA
(Zymo-Research, 2012). At this point the isolated, cleaned, and concentrated RNA was
quantified using the Qubit™ RNA Assay Kits for use with the Qubit® 2.0 Fluorometer
(Invitrogen, 2010). All eight samples processed through RNA cleanup yielded varied
amounts between 4 ng/µL to above the linearity of the Qubit, which was more than
sufficient enough continue on to the TruSeq RNA preparations.

Sample Preparation
RNA was fragmented and primed for first strand cDNA synthesis by the addition
of 18µL of “Elute, Prime, Fragment” mix to 5µL sample and placed in a sealed plate into
thermal cycler at 94°C for 8 minutes. The cleaved RNA fragments (primed with random
hexamers) were then reverse transcribed into the first cDNA (Illumina®, 2012) using
reverse transcriptase and random primers. First Strand Mix was first combined with 50µL
SuperScript II then 8µL of First Strand Mix and SuperScript II mix was added to each
well of cDNA plate and gently mixed. The sealed cDNA plate was placed on a pre-heated
thermal cycler with the following program: 25°C for 10 minutes, 42°C for 50 minutes,
70°C for 15 minutes, Hold at 4°C (Illumina®, 2012).
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The cDNA plate was removed from the thermal cycler to add 25µL of Second
Strand Master Mix to each well and mix gently. Plate was sealed and placed on thermal
cycler to incubate at 16°C for one hour. AMPure XP beads (Solid Phase Reversible
Immobilization- SPRI, Agencourt® AMPure® XP, product no. A63881) were used to
separate the ds cDNA from the second strand reaction mix.
To purify the ds cDNA, 90µL AMPure XP beads were added to each well
containing 50µL of ds cDNA and mixed gently. Plate was incubated for 15 minutes at
room temperate then placed on a magnetic strand for 5 minutes to ensure all beads are
bound to side of wells. Prior to wash step, 135µL of the supernatant was removed and
discarded from each well. A total of two washes were completed (on magnetic stand) by
the addition of 200µL 80% ethanol to each well at 30 second incubation cycles. The plate
was then allowed to dry for 15 minutes, resuspended with 53µL Resuspension Buffer
(plate was removed from magnetic stand at this point), incubated for 2 minutes at room
temperature, then placed on magnetic stand for 5 minutes, and finally the supernatant
(50µL) containing the ds cDNA was transferred to new well. Each well/sample that
contains 50µL ds cDNA was resuspended in 10µL of Resuspension Buffer, 40µL of End
Repair Mix was added, mixed thoroughly, and sealed. The sealed plate was then added to
the pre-heated thermal cycler to incubate at 30°C for 30 minutes (Illumina®, 2012).
Next, a cleanup procedure was performed as follows: 160µL of well mixed
AMPure XP beads were added to each well containing 100µL of End Repair Mix and
mixed gently and thoroughly. The plate was incubated for 15 minutes at room temperate
then placed on magnetic strand for 5 minutes to ensure all beads are bound to side of
wells. Prior to wash step, 127.5µL of the supernatant was removed and discarded from
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each well. A total of two washes were completed (on magnetic stand) by the addition of
200µL 80% ethanol to each well at 30 second incubation cycles. The plate was then
allowed to dry for 15 minutes, resuspended with 18µL Resuspension Buffer (plate was
removed from magnetic stand at this point), incubated for 2 minutes at room temperature,
then placed on magnetic stand for 5 minutes, and finally 15µL of the supernatant was
transferred to new well (Illumina®, 2012).
Next, 2.5µL of Resuspension buffer and 12.5µL A-Tailing Mix (in that order)
was added to each well, gently mixed, sealed, and incubated on thermal cycler at 37°C
for 30 minutes (Illumina®, 2012). To each well, 2.5µL of appropriate RNA adapter
Index, and 2.5µL of Ligation Mix (in that order) were added. Wells were gently mixed;
plate was sealed and incubated on a pre-heated thermal cycler at 30°C for 10 minutes. To
stop ligation, plates were removed from the thermal cycler and 5µL of Stop Ligation
(Illumina®, 2012) was added to each well and gently mixed.
After the addition of the Stop Ligation, samples were “cleaned” twice more using
AMPure XP beads and a series of washes as follows: 42µL of AMPure XP beads were
added to each well. The plate was incubated for 15 minutes at room temperate then
placed on magnetic stand for 5 minutes to ensure all beads are bound to side of wells.
Prior to wash step, 79.5µL of the supernatant was removed and discarded from each well.
The samples were then washed twice, dried, and resuspended with 53µL Resuspension
Buffer (plate was removed from magnetic stand at this point). The plate was incubated
for 2 minutes at room temperature, then placed on magnetic stand for 5 minutes, and
50µL of supernatant was transferred into new well or plate (if necessary). Cleanup was
performed a second time with the addition of 50µL of AMPure XP beads. Post washed
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samples were resuspended with 23µL of Resuspension Buffer and 20µL of supernatant
was transferred into a new well (Illumina®, 2012)
DNA fragments were enriched using a short PCR step. First, 5µL of PCR primer
Cocktail and 25µL of PCR Master Mix, respectively, was added to each well. The PCR
plate was added to a pre-heated thermal cycler with the following program: 98°C for 10
seconds;15 cycles of: 98°C for 10 seconds, 60°C for 30 seconds, and 72°C for 30
seconds; 72°C for 5 minutes; hold at 10°C. A post PCR cleanup (as described above) was
performed with the addition of 50µL of AMPure XP beads to wells containing 50µL of
PCR amplified library. Post washed samples were resuspended with 33µL of
Resuspension Buffer and 30µL of supernatant was transferred into a new well.

Next Generation Sequencing and Assembly
Following DNA fragmentation, adapter ligation, and PCR enrichment, adapterligated sequences are prepared for clustering and sequencing in a fully automated fashion
on Illumina’s MiSeq. The quality of the post-run data generated from the MiSeq was then
checked using PRINSEQ (Schmieder and Edwards, 2011). PRINSEQ is a tool that
generates summary statistics of sequence and quality data. Quality control measures used
for this study were as follows; length distribution, base qualities distribution, GC content,
and sequence complexity.
All sequences were assembled using SeqMan NGen® (DNAstar) engine via
template assembly using reference genome West Nile virus strain NY99 (GenBank
accession no. DQ211652). Contigs were aligned to the reference genome for further
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analysis in SeqMan Pro. Consensus sequences were exported and saved in FASTA file
formats for further analysis.

Molecular Phylogeny
To better understand the phylogenetic relationships among the WNV isolates and
to establish a suitable methodology for this dataset, several trees were reconstructed for
this study. Due to the vast amount of methods and parameters that can be used for
phylogeny studies initial tests involved simulation studies of previously, well established
studies, Davis et al. (2005), McMullen et al. (2011), Gray et al. (2010), Herring et al.
(2007) and Lanciotti et al. (2002).
Final comparison studies of the ENV (envelope), NS3 and NS5 genes and complete
genome were reconstructed in this study. The ENV, NS3, and NS5 genes were chosen
specifically to determine which gene was most phylogenetically informative for this
particular dataset and as a comparative study among the previously established works.
Tree reconstruction for this study was carried out in three steps; obtaining the
comparative data (sequence homologs) and aligning DNA sequences, converting the
comparative data into a reconstructed tree, and finally assessing the accuracy of the
reconstructed tree.

Obtaining Sequences
For simulation studies of previously published work, sequences were obtained
using either NCBI query by GenBank accession number or BLAST search for sequences
not identified by their GenBank accession number.
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For the final data set, sequences were either selected from Davis et al. (2005),
Herring et al. (2007), and McMullen et al (2011), or from a BLAST search using
MEGA5 (Hall, 2013; Tamura et al., 2011), to identify sequences that are homologous to
West Nile Virus NY99. A total of 68 sequences were selected (table 2) for the
reconstruction of the “master” tree. For the partial genome trees and other comparison
trees, 54 sequences were then selected from the “master list” to help resolve the topology,
thus providing for better resolution.

Alignments
Two of the most popular methods for aligning sequences include, MUSCLE
(Edgar, 2004) and ClustalW (Thompson et al., 1994), however, ClustalW is more widely
used. This study sought to determine the best method for the dataset by first attempting to
replicate previously published studies. For example, Davis et al. (2005) used AlignX
from the Vector NTI Suite package (Davis et al., 2005), a software program that aligns
sequences using the ClustalW algorithm. Therefore, alignment testing began with using
ClustalW in both MEGA 5.0 and AlignX, varying “Multiple Alignment” parameters such
as, “Gap Opening Penalty” and “Gap Extension”. MUSCLE alignment tests were
approached in a similar fashion, only changing one parameter at a time and holding all
others constant.
A study by Thompson et al. (1999) showed that when the average percent
amino acid identity in pairwise comparisons is too low, the accuracies of multiple
alignments fall below the level where they are able to produce reliable phylogenetic trees
(Thompson et al., 1999). The study demonstrated that when the average amino acid
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identity is <20% then 50% of the residues are correctly aligned (Thompson et al., 1999).
Therefore, to assess the reliability of all alignments one or both of the following methods
were used: average nucleotide/amino acid identity (overall p-distance) (Kumar and
Filipski, 2007; Thompson et al., 1999) and evaluation of bootstrap values of tree
reconstructs.
Upon completion of alignment experiments, this study found MUSCLE to be
more accurate, thus all trees were aligned using MUSCLE for coding sequences with user
default settings ( ‘Gap Opening Penalty’ set for -400, 8 max iterations and UPGMB
clustering method for all iterations) (Edgar, 2004). For partial gene reconstructions,
Florida/Georgia isolates were first aligned to NY99 (GenBank accession no.
DQ211652.1) using MUSCLE via MEGA5 software (Hall, 2013; Tamura et al., 2011),
then exporting to BioEdit Sequence Alignment Editor (version 7.2.3) (Hall, 1999) for
selection of the ENV, NS3, and NS5 genes. Selection for genes were based on NY99
(GenBank accession no. DQ211652.1) sequence annotated features listed on NCBI;
position 967 to 2469, 4612 to 6468, and 7681 to 10395, respectively.

Tree Reconstructions and Assessments
There are a number of methods currently being used to estimate the tree from
sequences and within the field of phylogenetics, the “best” method can be quite
contentious. Among the studies being tested, the majority used Maximum likelihood
(ML) or Bayesian methods. Maximum likelihood attempts to infer an evolutionary tree
by finding which tree maximizes the probability of observing the data and produces a
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single tree whereas Bayesian seeks those trees with the greatest likelihoods given the
data, producing several trees.
Software choice adds a second variable to the tree reconstruction as there are
several different programs for Maximum likelihood (ML) and Bayesian methods. Mr.
Bayes is most commonly used for Bayesian analyses, however its lack of graphical user
interface makes it a difficult choice for most users. Software selection for ML methods is
more extensive, thus providing the user the ability to choose a program that better suits
the needs of the study. The most commonly used programs are the Phylip package,
PAUP, MEGA, and PhyML. Phylip is a very large suite that has been distributed since
1980 and is therefore considered the “granddaddy” of all phylogenetic packages (Hall,
2011). PAUP is a multifeatured program which estimates trees by almost all methods
except Bayesian (Hall, 2011). PAUP is one of the most popular programs among
experienced users; however its latest version has not been fully tested. MEGA provides
for a user friendly interface, but is restricted to distance and likelihood methods. Lastly,
PhyML is a simple, fast, algorithm that can handle large phylogenies and implement
statistical support (Guindon and Gascuel, 2003).
Because this study sought to simulate previous studies to establish a
methodology that would consistently produce quality results, initial methods used were
dependent on the study being tested and contingent upon freely available software. Given
the comparative nature of this approach, workflows were created using Armadillo and
Mobyle platforms to facilitate the comparison of methods (Lord et al., 2012; Néron et al.,
2009). Mobyle platform is server based whereas Armadillo processes locally.
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Additionally, Mobyle allows the use of Mobyle created workflows (Néron et al., 2009)
and therefore was the primary source of final tree reconstructions for this study. Once a
consistency of quality among the previously published work was establish, newly
sequenced Florida/Georgia isolates were added to alignments and final trees were
reconstructed using PhyML, Maximum likelihood principle and bootstrapped with 500
replicates.

Phylogenetic Networks
A phylogenetic network is defined as “any network in which taxa are represented
by nodes and their evolutionary relationships are represented by edges” and plays an
important role for understanding the relationships within species or closely related
sequences (Hall, 2013; Huson and Bryant, 2006). To further show the evolutionary
history of the Florida/Georgia isolates among selected previously published isolates, thus
provide an illustration of “alternative” method a phylogenetic network was estimated
Neighbor-net algorithm and bootstrapped with 1000 replicates using SplitsTree (Huson
and Bryant, 2006).
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Table 2: Master List of West Nile Virus Strains Used to Study Genetic Evolutions

P=RNA extracted from infected tissue. V=RNA extracted from original isolation in Vero cells. V1=RNA
extracted after single Vero cell passage. V2=RNA extracted after second Vero cell passage.
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CHAPTER FIVE: RESULTS AND DISCUSSION
Results
Quality Controls
Prior to processing next generation generated data, PRINSEQ software was
utilized to measure the quality of the run before proceeding further downstream. Quality
control measures used for each sample in this study are as follows; length distribution,
base qualities distribution, GC content, and sequence complexity. All runs that were
accepted to proceed further downstream for analysis had Q scores of 75% >Q30 (optimal,
80%>Q30), meaning 75% of the reads had Q scores greater than 30 (1 in 1000 error
probability). Regardless of the 5% decrease from optimal, post run quality control using
PRINSEQ showed that the data was indeed acceptable to proceed further downstream.
Alignment reliability for all trees were also assessed (post alignment), using the
‘Overall Mean Distance’ calculation in MEGA5 (Tamura et al., 2011). An alignment is
said to be reliable if the nucleotide p-distance is <0.33 (or <0.8 for amino acid p-distance
(Hall, 2011; Kumar and Filipski, 2007; Thompson et al., 1999). The overall p-distance
value for the “Master” alignment met this reliability limit at 0.014 (nucleotide p-distance)
and 0.028 (amino acid p-distance).
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Phylogenetic Analysis
Phylogenetic analysis was completed using whole and partial genome sequences
from the determined West Nile virus strain data isolated from bird populations within
Florida and Georgia during 2002 through 2012 (figure 4 ). Other comparable whole
genome sequences were downloaded from GenBank.
Figure 4 depicts the deduced phylogenetic relationships among the WNV isolates
(complete genome) sequenced for this study and selected isolates from previously
published works, Davis et al. (2005) and McMullen et al. (2011) based on PhyML
maximum likelihood analysis, condensed to show only nodes with >80% bootstrap
support. US isolates are segregated into three major groups as previously defined: Eastern
US, intermediate, and WN02 genotypes (Davis et al., 2005; Ebel et al., 2004).
Another recent study suggested a new emerging genotype, termed SW/WN03
within the WN02 genotype which is also depicted in figure 4. This study was able to
resolve phylogenetic trees reconstructed similar to that of previously well-established
studies with few exceptions. For example, earlier WNV isolates sampled from
northeastern US (1999-2003), FL 2009-085 isolate and one isolate from Texas during
2004 formed the NY99 genotype for this study. However, isolate TX 2004 Harris 4 was
previously defined as a variant of NY99 and well established within the WN02 genotype
(Davis et al., 2005). Additionally, FL 2009-085 was unresolved with low bootstrap
values. Therefore, this study found these two isolates to be outliers and unresolved using
the PhyML method.
The intermediate genotype observed here contained six isolates from Florida (FL
2003-1354, sequenced in this study and FL 2003-113 from Herring et al. (2007)), Ohio,
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New York, and Mexico (2000-2003) and is consistent with previously established study,
Davis et al (2005). The remaining viruses clustered together to form the WN02 genotype
which is well distributed across the US (figure 4).
Within the WN02 genotype as described in McMullen et al. (2011) is the
SW/WN03 genotype which was found based on phylogenetic analysis and nucleotide and
amino acid substitutions and is composed of five groups (McMullen et al., 2011). For the
purposes of this study, only a select few isolates from this genotype were selected here
for phylogenetic analyses and are indicated by asterisks on figure 4.
Three of the five groups were partially resolved here with bootstrap values that
ranged from 80-99%. Termed previously as group 5, this group consisted of five isolates;
two from Arizona, two from Colorado, and one from TX (2004-2007) (McMullen et al.,
2011). Group 3, consisted of five isolates; two from Illinois, two from New York and one
from New Mexico (2004-2008) (McMullen et al., 2011). Lastly, group 2 was composed
of five isolates; one from Florida isolate sequenced in this study (FL 2009-086), three
from Texas, and one from Colorado.
In addition to the SW/WN03 genotype, figure 4 depicts five other clusters within the
WN02 clade. Groups 1-3 are 2003 isolates, previously identified by May et al. (2010) in a
phenotypic and phylogenetic study (May et al., 2010). Group 1 contains four isolates; one
from Colorado and three from Texas (figure 4). Of the three from Texas, two have been
shown to be virulent strains, TX 2003 Harris 6 and Harris 7 (May et al., 2010). Group 2
contains five isolates, all from Texas, two isolated from birds and three from mosquitos
(table 2, figure 4). Group 3 contains one virulent strain, TX 2003-1576 isolated from a
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blue jay, one attenuated strain TX 2003-1175, and TX 2003 isolated from a human blood
donor (figure 4) (May et al., 2010).
Termed here, Group 4 is a small group of three isolates, all newly sequenced for
this study isolated in 2012 from Florida (FL 2012-041) and Georgia (GA 2012-028 and
GA 2012-030). Group five, the largest of the clusters, is the most basal group within the
WN02 clade and contains nine isolates; three from New York (2002-2003), three from
the newly sequenced Florida isolates (2003-2004), and three from Texas (2002-2004).
Phylogenetic networks were used here to facilitate visualization of the genetic
relationship between the WNV isolates (Hall, 2011; Huson and Bryant, 2006). Network
analysis was performed using whole genome sequences from this study and other select
sequences from previous studies and is shown in figure 5 (table 2). Figure 5 depicts a
similar grouping as seen in the ‘master’ phylogenetic tree (figure 4) and is well
supported. Parallel lines (not depicted here) are edges (or branches) that indicate
alternative inconsistent evolution. For example, there are several ‘parallel lines, or
inconsistencies within the NY99 clade, indicating that there are many alternative
evolutionary trajectories possible and is similar to the many polytomes seen in pervious
studies of the NY99 clade. Though parallel lines are difficult to see here without zooming
in very closely, they can be seen by the thickness of the connecting lines as this thickness
is directly related to the amount of parallel lines present.
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Figure 4: A phylogenetic analysis of WNV complete genomes- Master Tree
Isolates sequences in this study are shown in bold, selected isolates from Davis et al. (2005) are in italic font, and
isolates from McMullen are indicated with an asterisk (*). Numbers at nodes indicate bootstrap values >80%.

SW/WN03 genotype

North American Isolates (WN02) 2002-2012

Intermediate

Eastern US
Old World
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Figure 5: Phylogenetic Network of WNV isolates
Isolates are color coded in groups. Within the ‘Old World’ clade are in black font, NY99 in green, intermediate in light blue, WN02,
in blue, SW/WN02 in purple, and Florida/Georgia isolated sequenced in this study in red.
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To test which region of the genome is more phylogenetically informative thus
producing a tree that more closely resemebles that of complete genome, the ENV, NS3,
and NS5 trees were reconstructed by maximum likelihood (PhyML) and condensed to
show only nodes with >80% suppport (figure 6). Sequences selected for the partial
genome trees came from the 10 newly sequenced Florida/Georgia isolates and sequences
used in Davis et al. (2005) (metadata for these isolates are listed in table 2). The ENV
tree in figure 6 (left) shows an unresolved pattern (ie. polytomes and lack of separation of
clades) and is consistent with what was found in Gray et al. (2010), suggesting that the
envelope region might not be the most phylogenetically informative. (Gray et al., 2010).
Interestly, the NS5 gene tree (figure 6, right) was also unresolved, with no supported
seperation of the NY99 isolates and the WN02. However, within the large grouping the
NS5 tree does show a supported grouping of the “Intermediate” clade. The NS3 tree
(figure 6, middle), was most resolved and depicts well supported separation of the NY99,
WN02, and Intermediate clades . This suggests that the NS3 gene , in agreement with
Gray et al. (2010), is the most phylogenetically informative among the three and more
closely resembles phylogeny of whole genome (Gray et al., 2010)
To estimate the evolutionary divergence between Florida/Georgia sequence
strains and NY99-flamingo (GenBank accession no. AF196835.2), a pairwise distance
was computed for both complete and partial genomes (ENV, NS3, and NS5 genes)
alignments and shown in tables 3 through 6. The greatest percent divergence of
Florida/Georgia isolates across the complete genome was between FL 2009-86 isolate
and all 2012 isolates, with a percent nucleotide divergence of approximately 1.0%
(shown in table 3).
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Figure 6: Phylogenetic Tree Reconstructions (partial genomes)
Maximum likelihood phylogenetic trees based on the E gene (left), NS3 (middle), and NS5 (right). Isolates sequenced in this study are
in bold.

ENV

NS3
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NS5

Pairwise distance analysis of the ENV and NS3 showed similar findings with
divergence between the 2012 isolates and FL 2009-086 isolate at 0.93% and 0.92%,
respectively (table 4 and 5). Interestingly, the NS5 region showed a slightly higher
percent divergence between the 2012 isolates and the FL 2009-086 isolate (table 6).
These findings might suggest an introduction of a new genome cluster occurring
sometime between 2009 and 2012 and is consistent with the grouping of 2012 isolates in
all trees.
Ordering the Florida/Georgia isolates by collection dates (ascending order), table
3 shows a relative increase in the percent nucleotide divergence from NY99-flamingo
(GenBank accession no. AF196835.2) (2003, 0.30%; 2012, 0.61%) with a few
exceptions; FL 2009-86 and GA 2012-28 with slightly higher percentages of 0.63% and
0.64%, respectively. Interestingly two isolates from 2003(FL 2003-1396 and FL 20031952) and one from 2009 (FL 2009-85) were less divergent from NY99-flamingo strain
than their preceding strains (table 3), indicating the possibility of dual circulating
populations during this time frame. The split between FL 2003-1396 and FL 2003-1952
is further supported with the tree reconstruction shown in figure 4. However only one of
the 2009 (FL 2009-086) isolates is further supported with the phylogenetic tree.
When looking at the E gene only, similar patterns were seen among the 2003 and
2009 isolates as described above with one exception; FL 2009-86 is relatively more
divergent from NY99-flamingo than the 2012 isolates (table 4). This is not the case,
however, with the NS3 and NS5 regions as seen in tables 5 and 6.
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To further demonstrate the degree to which the Florida/Georgia isolates have
diverged from year to year, nucleotide sequences for the complete genome were grouped
by year and the average pairwise distances between groups were calculated. Table 7
shows results consistent with previous observations, with percent nucleotide divergence
from WN-NY99-flamingo generally increasing over time (2003, 0.30%; 2012, 0.66%).
Isolates from 2009 remained on average slightly less divergent from WN-NY99 (0.34%)
than were 2004 isolates (0.40%). In addition, table 7, consistent with previous results,
shows that the highest divergence occurs between 2009 and all 2012 isolates (0.84%).
When comparing the divergence tables, complete versus partial genome, some
similarities exist when looking at relative changes over time. However, there notable
differences such as the overall average percentage divergence of Florida/Georgia isolates
when compared to NY99-flamingo; 0.36% for the envelope region, 0.40% for the NS3,
0.47% for NS5, and 0.40% for complete genome. This observation suggests that the NS3
region might be better representative of complete genome over the NS5 and envelope
gene and correlates with recent studies showing the NS3 region can provide phylogenetic
reconstruction that closely relates to that of complete genome (Gray et al., 2010) and can
be further observed in the partial genome phylogenetic trees (figure 6). Additionally, FL
2009-86 and GA 2012-28 are notably different when observing among partial genomes.
For example, the ENV gene showed FL2009-86 having a significantly larger percent
divergence from NY99-flamingo than any other 2012 isolate. Whereas differences over
NS3, NS5 and complete genome showed only a marginal difference between other 2012
isolates when compared to NY99 (tables 4-6). Lastly, the minimum percent nucleotide
divergence from NY99-flamingo was different for partial and complete genome analysis;
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for E gene minimum percent is seen for FL 2003-1354 (0.07%) and isolate FL 2009-85
(0.10%) over complete genome.
Overall nucleotide divergence of all Florida/Georgia isolates and GenBank
sequences from NY99-flamingo is 0.31% (not shown here). Maximum divergence among
all sequences was between FL 2009-086 isolate and GA 2012- 028 with 1.03%
divergence. These findings suggest that while WNV has continued to diverge over the
years, even viruses circulating in the same location, as seen in 2003 and 2009, continually
diverge from one another.

Discussion
Advances in molecular technologies have allowed for the relatively rapid
identification of unknown viral agents. Utilizing next-generation sequencing for this
study has facilitated the feasibility of obtaining complete genome sequences within a
relatively short period. As described previously, the objectives for this project are: to
establish a phylogeny method suitable for the evolutionary analyses of the
Florida/Georgia dataset, characterize the phylogenetic relationship and nucleotide
sequencing homology for Florida/Georgia isolates to previously reported isolates, and
finally, to study the evolution of West Nile virus at a localized level.
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Table 3: Percentage nucleotide divergence over complete genome of Florida/Georgia WNV isolates sequenced in this
study.
The number of base differences per site from between sequences are shown. The analysis involved 11 nucleotide sequences.
There were a total of 11056 positions in the final dataset. Evolutionary analyses were conducted in MEGA5 (Tamura et al.,
2011).

Strain

NY99flamingo FL_2003- FL_2003- FL_2003- FL_2003- FL_2004- FL_2009- FL_2009- GA_2012- GA_2012382-99
1354
1396
1406
1952
455
085
086
028
030

NY99flamingo382-99
FL_2003-1354
FL_2003-1396
FL_2003-1406
FL_2003-1952
FL_2004-455
FL_2009-085
FL_2009-086
GA_2012-028
GA_2012-030
FL_2012-041

0.30%
0.24%
0.33%
0.21%
0.36%
0.10%
0.63%
0.64%
0.61%
0.61%

0.41%
0.46%
0.38%
0.50%
0.34%
0.78%
0.78%
0.74%
0.78%

0.33%
0.21%
0.34%
0.28%
0.61%
0.66%
0.63%
0.63%

0.32%
0.45%
0.37%
0.70%
0.73%
0.68%
0.70%

0.34%
0.25%
0.60%
0.63%
0.60%
0.60%

43

0.41%
0.71%
0.79%
0.75%
0.75%

0.67%
0.69%
0.65%
0.65%

1.03%
1.00%
1.02%

0.40%
0.44%

0.40%

Table 4: Percentage nucleotide divergence over partial (ENV) genome of Florida/Georgia WNV isolates sequenced in
this study.
The number of base differences per site from between sequences are shown. The analysis involved 11 nucleotide sequences.
Evolutionary analyses were conducted in MEGA5 (Tamura et al., 2011).
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Table 5: Percentage nucleotide divergence over partial (NS3) genome of Florida/Georgia WNV isolates sequenced in
this study.
The number of base differences per site from between sequences are shown. The analysis involved 11 nucleotide sequences.
Evolutionary analyses were conducted in MEGA5 (Tamura et al., 2011).

Strain
NY99-Flamingo
FL_2003-1354
FL_2003-1396
FL_2003-1406
FL_2003-1952
FL_2004-455
FL_2009-085
FL_2009-086
GA_2012-028
GA_2012-030
FL_2012-041

NY99flamingo
0.33%
0.22%
0.27%
0.38%
0.22%
0.16%
0.54%
0.65%
0.54%
0.71%

FL_2003- FL_2003- FL_2003- FL_2003- FL_2004- FL_2009- FL_2009- GA_2012- GA_20121354
1396
1406
1952
455
085
086
028
030

0.33%
0.38%
0.49%
0.33%
0.49%
0.65%
0.76%
0.65%
0.82%

0.16%
0.27%
0.11%
0.38%
0.44%
0.54%
0.44%
0.60%

0.33%
0.16%
0.44%
0.49%
0.60%
0.49%
0.65%

0.27%
0.54%
0.60%
0.71%
0.60%
0.76%
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0.38%
0.44%
0.54%
0.44%
0.60%

0.71%
0.82%
0.71%
0.87%

0.76%
0.76%
0.92%

0.11%
0.27%

0.16%

Table 6: Percentage nucleotide divergence over partial (NS5) genome of Florida/Georgia WNV isolates sequenced in
this study.
The number of base differences per site from between sequences are shown. The analysis involved 11 nucleotide sequences.
Evolutionary analyses were conducted in MEGA5 (Tamura et al., 2011).

Strain
NY99_Flamingo
FL_2003-1354
FL_2003-1396
FL_2003-1406
FL_2003-1952
FL_2004-455
FL_2009-085
FL_2009-086
GA_2012_28
GA_2012-30
FL_2012-041

NY99flamingo
0.33%
0.33%
0.33%
0.19%
0.41%
0.11%
0.74%
0.74%
0.71%
0.74%

FL_2003- FL_2003- FL_2003- FL_2003- FL_2004- FL_2009- FL_2009- GA_2012- GA_20121354
1396
1406
1952
455
085
086
028
030

0.52%
0.52%
0.37%
0.52%
0.37%
0.86%
0.86%
0.82%
0.93%

0.45%
0.30%
0.52%
0.37%
0.86%
0.86%
0.82%
0.86%

0.30%
0.52%
0.37%
0.86%
0.86%
0.82%
0.78%

0.37%
0.22%
0.71%
0.71%
0.67%
0.71%
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0.45%
0.89%
0.93%
0.89%
0.93%

0.78%
0.78%
0.74%
0.78%

1.26%
1.23%
1.26%

0.41%
0.52%

0.48%

Table 7: Average pairwise percent nucleotide divergence (complete genome)
between groups* per year
The number of base differences per site from averaging over all sequence pairs between
groups are shown. The analysis involved 11 nucleotide sequences. All ambiguous
positions were removed for each sequence pair. There were a total of 11056 positions in
the final dataset. Evolutionary analyses were conducted in MEGA5.
Group

1999

2003

2004

2009

1999
2003

0.30%

2004

0.40%

0.41%

2009

0.34%

0.49%

0.56%

2012

0.66%

0.68%

0.76%

0.84%

Note: Groups include only Florida/Georgia isolates sequenced in this study only.
Aim One:
Utilizing previously well-established studies as a baseline approach to establish a
“standard” method that would provide well supported phylogenetic trees that not only
replicated conclusions from past studies but also allowed for statistically significant
inference to be drawn for the Florida/Georgia isolates proved to be an essential,
successful approach. Interestingly, this study found that using the popular ClustalW
algorithm for alignments was not ideal for this dataset. Tree reconstructions made from
ClustalW alignments were not statistically supported and unresolved. Moreover, utilizing
the “exact” methods used in the previously described studies (Davis et al. (2005),
McMullen et al. (2011), among others) was not necessarily feasible. For example, as
described previously, more popular methods such as Bayesian inference requires the use
of esoteric software which can be difficult for the inexperienced user. This study,
therefore, sought to find a method that was suitable for this dataset, feasible for the
novice computer scientist, and most importantly, produced statistically reliable results
comparable to other well-establish studies. As described in a previous section, this was
accomplished by an exploratory approach of “trial and error.” Several experimental trees
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were reconstructed by a variety of methods; some variables (e.g. alignment methods and
parameters, phylogeny methods and parameters, software programs and options) were
held constant while others were changed, or were removed. After numerous tests,
PhyML, a maximum likelihood principle, reproduced the resulting trees presented in this
study. These trees showed sound statistical support comparable to other published work
and maintained this consistently among all trees indicating that this method is suitable for
this dataset and perhaps other similar datasets.
Aim Two:
Since West Nile virus was identified in 1999, phylogenetic studies have provided
much insight into its geographical and temporal spread and evolution. Well documented
location and year of the first virus isolates and continuous tracking of later isolates, along
with molecular epidemiological studies have enabled scientists to make genetic
inferences between isolates made at the inception of WNV into North America and from
years following over a broad geographic distribution (Davis et al., 2005; Ebel et al., 2004;
Ebel et al., 2001; Hayes, 2001; Jia et al., 1999; Lanciotti et al., 1999; Lanciotti et al.,
2002; May et al., 2011). Thus, genome sequences from isolates made in 1999 provided a
“genetic baseline” (Pesko and Ebel, 2012) for future studies and the discovery of a new
dominant genotype, North American WN02. Several studies showed that NY99 had been
displaced by WN02 sometime between 2002 and 2003. The phylogenetic analysis of the
Florida/Georgia isolates sequenced in this study present similar findings as a majority of
the isolates sequenced in this study sit well within the WN02 clade with few exceptions.
An interesting observation seen in both the complete genome and partial NS3 gene is
Florida isolate 1354 which sits basal to the WN02 clade within the intermediate clade
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while all other isolates (except FL 2009-086) were within the WN02 clade. Isolate FL
2003-1354 was collected on the same day as FL 2003-1406, from two counties
approximately 69 miles from each other. Interestingly, these isolates had only 0.41%
nucleotide divergence from each other when observing over the complete genome,
however, each isolate sits within two previously defined, separate genotypes,
intermediate and WN02. This suggests that sometime during 2003 there was a diversion
either during the introduction of WN02 into Florida or after. However, time scale
analysis was not done in this study to support this speculation further.
The two 2009 isolates from this study presented similarly with a moderately
increased divergence from both the NY99 reference and from each other as discussed
previously. McMullen et al. (2011) showed among isolates studied, that from 2005-2009
there was a reversion to NY99 genotype seen at 4 nucleotide positions (McMullen et al.,
2011). Phylogenetic analysis in this study suggests that this might be the reason for the
split between the two 2009 isolates, FL 2009-085 and FL 2009-086. However, isolate FL2009-085 was not well supported in the phylogenetic analysis as it was unresolved with
low bootstrap value (<80%) and lack of grouping. Therefore further testing is needed to
further define where the FL 2009-085 isolate should sit within the phylogeny tree.
When compared with other North American isolates (figure 4), a distinct cluster
within the WN02 genotype was found. This 2012 cluster, “group 4” was evident in every
phylogeny test, including experimental tests. Further testing, such as, amino acid
substitutions and phenotypic analysis, are needed to establish why this cluster is so
consistently supported while other clusters have a tendency to fluctuate with
methodology or region used.
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Another Florida isolate sequenced in this study, FL 2009-086, was found to be
within the SW/WN03 genotype and shows strong bootstrap support in both the master
tree and the NS5 tree (figure 4 and 6). Figure 4 shows that this isolate belongs to the
previously established “SW/WN03 group 2” and is most closely related to an isolate from
Texas, TX 2008-7558. The SW/WN03 genotype was first identified in 2003 in Texas and
was further classified in a 2011 McMullen et al. study when they found several more
isolates shared this genotype and were spreading to other geographical locations such as
California, New Mexico, New York, North Dakota and upper Texas gulf coast regions
(McMullen et al., 2011). Although, the SW/WN03 genotype was establish in the
McMullen et al (2011) and one other study (Anez et al. 2013), it was only partially
resolved here. The group was well separated from other isolates within the WN02
however the group itself contained unresolved areas (i.e. many polytomies). Genetic
similarity between FL 2009-086 and the 2008 TX isolate, suggests that the cluster found
here might be related to the SW/WN03 genotype, thus indicating the possibility that the
SW/WN03 genotype has spread further east into Florida.

Aim Three:
The majority of the isolates sequenced in this study are from within Florida with
only two from Georgia therefore this study was able to characterize West Nile virus
evolution at a more localized level. The isolates appear to be distributed within the three
clades, NY99, intermediate and WN02. Notably, as discussed previously, the distribution
appears to be uneven, regardless of transmission year and geographical location.
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Although there have been numerous phylogenetic studies regarding the evolution
of West Nile virus, they have been focused around the westward migration of the virus
and were discussed previously. To my knowledge there have been two West Nile
phylogeny studies conducted with isolates from Florida: Herring et al. (2007) and
Chisenhal et al., 2009. Herring et al. (2007) sequenced four samples from Florida blood
donors in 2003. Herring et al. (2007) showed an expansion of the previously identified
‘intermediate clade’ phylogenetically with isolate 113 (termed here as FL 2003-113)
(Herring et al., 2007). This study further demonstrated this expansion with the addition of
two more Florida isolates to this clade (figure 4), one sequenced here (FL 2003-1354)
and another previously sequenced (FL 2001 crow67030). Another study, Chisenhal et al.,
(2009) suggested that the WN02 genotype was introduced into Florida sometime between
2003 and 2005 (Chisenhall and Mores, 2009). This study affirms Chisenhal et al. with the
majority of the isolates sequenced in this study within the WN02 clade as shown in figure
4.
In 2012, Florida case reports reached their highest level since 2003 with 73 cases
(CDC, 2013b). Interestingly, the three 2012 isolates (termed here as group 4) sequenced
in this study demonstrated strong support among all experimental trees and resulting
trees. For example, while testing for a suitable method for this dataset, several trees were
produced, in one of the experimental trees (figure 7) additional isolates from Texas, one
from 2006 and six from 2009, formed together with the 2012 isolates, established a
unique grouping basal to all other North American (WN02) isolates. Interestingly, once
those set of sequences were removed the group remained well established and did not
move into the SW/WN03 as predicted. This suggests that the group of 2012 isolates have
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the potential of becoming a new genotype and is perhaps the reason for the highest case
reports Florida has seen since 2003. However, further experiments are needed to
investigate this group’s emergence and potential amino acid and phenotypic changes.
In conclusion, this study confirms the continuing evolution of and divergence of
circulating WNV in the Southeast US from NY99 and suggests the potential emergence
of the new SW/WN03 genotype into Florida as well as the forming of a new cluster,
termed here as group 4 consisting of three 2012 isolates from Florida/Georgia region.
Further, this study suggests that sometime during 2009 there was an introduction of the
SW/WN03 genotype and within that same year there appeared to be a movement into the
development of group 4, which consisted of all 2012 isolates, showed here in this study,
and other 2009 TX isolates (figure 7).
Finally, throughout the last 14 years West Nile virus has been one of the most
studied among the arboviruses. Throughout these studies WNV has proved to be an
“ecological generalist” (Pesko and Ebel, 2012) that continues to evolve. However, with
newer advances in technology and collaboration between people studying other related
subjects (ecology, entomology, molecular epidemiology, and spatial epidemiology)
which have provided much insight, there is still much to be learned about WNV,
regarding the interactions between virus, host and environment
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Figure 7: Snapshot of Experimental PhyML Phylogenetic Tree Reconstruction of “Group 4”
A maximum likelihood tree magnified to show “group 4” only. Group 4 contains all 2012 isolates and 7 isolates from Texas (20062009). Bootstrap values are shown at each node, where 1.000 is the max value (shown elsewhere as ‘100’). All nodes are strongly
supported at >89%. Tree shown here was edited using Dendroscope (version 2.3.8) magnifier option (Huson and Scornavacca, 2012).
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North American Isolates (WN02)
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